Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY – Get Free Report) shares fell 3.1% during trading on Thursday . The stock traded as low as $9.45 and last traded at $9.45. 1,148 shares changed hands during trading, a decline of 58% from the average session volume of 2,762 shares. The stock had previously closed at $9.75.
Clinuvel Pharmaceuticals Trading Down 1.1 %
The firm has a fifty day simple moving average of $9.65 and a 200 day simple moving average of $9.85.
Clinuvel Pharmaceuticals Increases Dividend
The business also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 9th were given a dividend of $0.0299 per share. The ex-dividend date of this dividend was Monday, September 9th. This is a boost from Clinuvel Pharmaceuticals’s previous dividend of $0.03.
About Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
Featured Articles
- Five stocks we like better than Clinuvel Pharmaceuticals
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Do ETFs Pay Dividends? What You Need to Know
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Overbought Stocks Explained: Should You Trade Them?
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Clinuvel Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinuvel Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
